National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting, 58746 [2024-15950]
Download as PDF
<![CDATA[
58746
Federal Register / Vol. 89, No. 139 / Friday, July 19, 2024 / Notices
www.hiv.gov/federal-response/pacha/
about-pacha prior to the meeting.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The meeting will convene on
Wednesday, August 28, 2024 from
approximately 1 p.m. to 5:30 p.m. (ET)
and Thursday, August 29, 2024 from
approximately 1 p.m. to 5:30 p.m. (ET).
National Institutes of Health
This meeting will be held
virtually. To stream the meeting, please
visit www.hhs.gov/live.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DATES:
ADDRESSES:
Ms.
Chloe Loving, MPH, Committee
Manager for PACHA, at PACHA@
hhs.gov or 202–795–7697. Additional
information can be obtained by
accessing the Council’s page on the
HIV.gov site at www.hiv.gov/pacha.
FOR FURTHER INFORMATION CONTACT:
PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996 and is currently operating
under the authority given in Executive
Order 14109, dated September 29, 2023.
The Council was established to provide
advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective HIV
diagnosis, treatment, prevention, and
quality care services. The functions of
the Council are solely advisory in
nature. The Council consists of not more
than 35 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
population health, philanthropy,
marketing or business, as well as other
national leaders held in high esteem
from other sectors of society. PACHA
selections also include persons with
lived HIV experience and persons
disproportionately affected by HIV.
Council members are appointed by the
Secretary.
SUPPLEMENTARY INFORMATION:
ddrumheller on DSK120RN23PROD with NOTICES1
Dated: July 9, 2024.
Caroline Talev,
Executive Director, Presidential Advisory
Council on HIV/AIDS, Senior Management
Analyst, Office of Infectious Disease and HIV/
AIDS Policy, Office of the Assistant Secretary
for Health, Department of Health and Human
Services.
[FR Doc. 2024–15964 Filed 7–18–24; 8:45 am]
BILLING CODE 4150–43–P
VerDate Sep<11>2014
18:53 Jul 18, 2024
Jkt 262001
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: September 17, 2024.
Open: 9:30 a.m. to 2:45 p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institutes of Health,
Building 31, 31 Center Street, Bethesda, MD
20892 (Hybrid Meeting).
Closed: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Street, Bethesda, MD
20892 (Hybrid Meeting).
Contact Person: Darren D. Sledjeski, Ph.D.,
Director, Division of Extramural Activities
(DEA), National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Blvd., Bethesda, MD 20892, (301)
451–7766, darren.sledjeski@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/about-
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
nih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.niams.nih.gov/about/working-groups/
advisory-council, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: July 16, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–15950 Filed 7–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Interventional Agents
Chemistry Services (IACS) Services.
Date: August 5–12, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Soheyla Saadi, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
E:\FR\FM\19JYN1.SGM
19JYN1
]]>Agencies
[Federal Register Volume 89, Number 139 (Friday, July 19, 2024)]
[Notices]
[Page 58746]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15950]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Arthritis
and Musculoskeletal and Skin Diseases Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Arthritis and Musculoskeletal and
Skin Diseases Advisory Council.
Date: September 17, 2024.
Open: 9:30 a.m. to 2:45 p.m.
Agenda: Discussion of Program Policies and Issues.
Place: National Institutes of Health, Building 31, 31 Center
Street, Bethesda, MD 20892 (Hybrid Meeting).
Closed: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Building 31, 31 Center
Street, Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: Darren D. Sledjeski, Ph.D., Director, Division
of Extramural Activities (DEA), National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701 Democracy Blvd., Bethesda,
MD 20892, (301) 451-7766, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the Institute's/Center's home
page: https://www.niams.nih.gov/about/working-groups/advisory-council, where an agenda and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: July 16, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-15950 Filed 7-18-24; 8:45 am]
BILLING CODE 4140-01-P
